(Q37964266)

26 August 2017

Proteinuria: detection and role in native renal disease progression (English)

1 reference

26 August 2017

1 reference

Jose Luis Gorriz

1

1 reference

PubMed ID

22137726

26 August 2017

Alberto Martinez-Castelao

series ordinal

2

1 reference

PubMed ID

22137726

26 August 2017

language of work or name

1 reference

1 January 2012

1 reference

26 August 2017

Transplantation Reviews

1 reference

26 August 2017

26

1 reference

26 August 2017

1

1 reference

26 August 2017

3-13

1 reference

Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Extended prognostic value of urinary albumin excretion for cardiovascular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Proteinuria and interstitial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Aliskiren combined with losartan in type 2 diabetes and nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Avosentan for overt diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Pathophysiology of Tamm-Horsfall protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Microalbuminuria in essential hypertension: redefining the threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Predicting diabetic nephropathy in insulin-dependent patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Current issues in measurement and reporting of urinary albumin excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Time to abandon microalbuminuria?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Association between albuminuria and proteinuria in the general population: the AusDiab Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Urine dipstick testing: comparison of results obtained by visual reading and with the Bayer CLINITEK 50

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Use of a first-line urine protein-to-creatinine ratio strip test on random urines to rule out proteinuria in patients with chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Diagnostic accuracy of the urinary albumin: creatinine ratio determined by the CLINITEK Microalbumin and DCA 2000+ for the rule-out of albuminuria in chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Postanalytical external quality assessment of urine albumin in primary health care: an international survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Characterization of immunochemically nonreactive urinary albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

A liquid chromatography-mass spectrometry method for the quantification of urinary albumin using a novel 15N-isotopically labeled albumin internal standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Prevention of diabetic renal disease with special reference to microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Management of glomerular proteinuria: a commentary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Testing for chronic kidney disease: a position statement from the National Kidney Foundation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

The urine albumin-to-creatinine ratio: assessment of its performance in the renal transplant recipient population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Staging of chronic kidney disease: time for a course correction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

The global burden of chronic kidney disease: how valid are the estimates?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Fact or fiction of the epidemic of chronic kidney disease--let us not squabble about estimated GFR only, but also focus on albuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Recent advances in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Obesity, proteinuria and progression of renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Effects of hypertension and dyslipidemia on the decline in renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Proteinuria in diabetic kidney disease: a mechanistic viewpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Cell biology of the glomerular podocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Renal albumin absorption in physiology and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

Transforming growth factor-beta1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

How does proteinuria cause progressive renal damage?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.10.002

10.1016/J.TRRE.2011.10.002

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22137726